Capsule garners $20 million in new capital. The company gets prescriptions from doctors via a mobile app and delivers prescriptions to the patient's home.
$130 million is a lot of money; it is a lot of capital. So why investors are giving it to Clover Health in a new financing round perplexes me, since it plows well-worn and not very fertile ground of doing data analytics and care coordination for Medicare Advantage patients.
Conversa, which, as the name suggests, facilitates health care conversations, raises $8 million in new capital. Conversely, the investors just threw money down yet another all-talk, no action, rabbit hole.
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.